Asian Phase I Study Of PF-03446962
NCT01337050
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
PF-03446962
Sponsor
Pfizer